Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece

被引：30
作者：
Chaniotaki, S
Giakouppi, P
Tzouvelekis, LS
Panagiotakos, D
Kozanitou, M
Petrikkos, G
Avlami, A
Vatopoulos, AC
机构：
[1] Natl Sch Publ Hlth, Dept Microbiol, Athens, Greece
[2] Laikon Gen Hosp, Dept Microbiol, Athens, Greece
[3] Univ Athens, Sch Med, Dept Microbiol, GR-11527 Athens, Greece
[4] Univ Athens, Infect Dis & Antimicrobial Chemotherapy Res Lab, Athens, Greece
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2004年 / 10卷 / 01期
关键词：
Community-acquired; Escherichia coli; quinolones; resistance; urinary tract infection;
D O I：
10.1111/j.1469-0691.2004.00807.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Susceptibility data for 10 049 Escherichia coli isolates derived from community-acquired urinary tract infections in Greece during the period January 2000 to June 2002 indicated 8.1% resistance to nalidixic acid and 36% resistance to ciprofloxacin. In a sample of 170 E. coli isolates, mutations in gyrA (25 isolates) and parC (15 isolates) were consistent with the levels of resistance to quinolones. Previous exposure to quinolones and underlying chronic disease were independent risk factors for infection by quinolone-resistant E. coli strains.
引用
收藏
页码：75 / 78
页数：4
相关论文
共 13 条
[1]   EMERGENCE OF QUINOLONE-RESISTANT ESCHERICHIA-COLI BACTEREMIA IN NEUTROPENIC PATIENTS WITH CANCER WHO HAVE RECEIVED PROPHYLACTIC NORFLOXACIN [J].
CARRATALA, J ;
FERNANDEZSEVILLA, A ;
TUBAU, F ;
CALLIS, M ;
GUDIOL, F .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) :557-560
[2]   RAPID EMERGENCE OF QUINOLONE RESISTANCE IN CIRRHOTIC-PATIENTS TREATED WITH NORFLOXACIN TO PREVENT SPONTANEOUS BACTERIAL PERITONITIS [J].
DUPEYRON, C ;
MANGENEY, N ;
SEDRATI, L ;
CAMPILLO, B ;
FOUET, P ;
LELUAN, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) :340-344
[3]   Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals [J].
Everett, MJ ;
Jin, YF ;
Ricci, V ;
Piddock, LJV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2380-2386
[4]   Emergence and dissemination of quinolone-resistant Escherichia coli in the community [J].
Garau, J ;
Xercavins, M ;
Rodríguez-Carballeira, M ;
Gómez-Vera, JR ;
Coll, I ;
Vidal, D ;
Llovet, T ;
Ruíz-Bremón, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2736-2741
[5]   Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis [J].
Horcajada, JP ;
Vila, J ;
Moreno-Martínez, A ;
Ruiz, J ;
Martínez, JA ;
Sánchez, M ;
Soriano, E ;
Mensa, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (01) :55-59
[6]   Improved repetitive-element PCR fingerprinting for resolving pathogenic and nonpathogenic phylogenetic groups within Escherichia coli [J].
Johnson, JR ;
O'Bryan, TT .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (02) :265-273
[7]   Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures [J].
McDonald, LC ;
Chen, FJ ;
Lo, HJ ;
Yin, HC ;
Lu, PL ;
Huang, CH ;
Chen, P ;
Lauderdale, TL ;
Ho, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) :3084-3091
[8]  
*NCCLS, 2000, METH DIL ANT SUSC TE
[9]  
NCCLS, 2000, PERF STAND ANT DISK
[10]  
PIDDOCK LJ, 1999, DRUGS S2, V58, pS11
12